Stieglitz R D, Zaudig M, Freyberger H J, Dittmann V
Department of Psychiatry, Free University Berlin, (West), Germany.
Pharmacopsychiatry. 1990 Jun;23 Suppl 4:188-91. doi: 10.1055/s-2007-1014563.
A total of 134 clinicians in 10 centres participated in the WHO-initiated field trial in German-speaking countries prior to the introduction of ICD-10 (chapter V; categories F00-F99. Mental, Behavioural, and Developmental Disorders), and provided 1,778 diagnostic assessments of 90 cases. Since these assessments were made in different phases of the field trial, the present study investigated how the "feasibility" and "suitability" of the so-called "Clinical Descriptions and Diagnostic Guidelines" was assessed within the individual phases. In addition, the interrater reliability of diagnostic assessments for the respective phases was investigated. The results show that ICD-10 was accepted both at the beginning of the study, and after several months of use. With respect to interrater reliability, improvements in some of the categories are necessary.
在引入ICD - 10(第五章;类别F00 - F99. 精神、行为和发育障碍)之前,来自10个中心的总共134名临床医生参与了世界卫生组织在德语国家发起的现场试验,并对90例病例进行了1778次诊断评估。由于这些评估是在现场试验的不同阶段进行的,本研究调查了在各个阶段如何评估所谓的“临床描述和诊断指南”的“可行性”和“适用性”。此外,还研究了各个阶段诊断评估的评分者间信度。结果表明,ICD - 10在研究开始时以及使用几个月后都被接受。关于评分者间信度,某些类别需要改进。